Visit Us at Booth 2172

ASGCT 27th Annual Meeting

May 7—11, 2024 | Baltimore, MD

Join us at the American Society of Gene + Cell Therapy (ASGCT) Annual Meeting in Baltimore happening from May 7-11! Visit us at booth 2172 to explore our capabilities in cell and gene therapy, including immunoassays, flow cytometry, efficacy, and biodistribution. This distinguished event brings together industry leaders and experts, offering an unmatched platform to learn key insights from top researchers and forge valuable connections.

Noble’s experienced quality and regulatory experts specialize in Cell and Gene Therapy IND-enabling studies, and can ensure that your data is fully prepared for FDA submission. We are proud to be your partner to support your research efforts in the field of cell and gene therapy, and lead you through each critical process during this transformative journey towards bringing revolutionary advancements to patients worldwide.

Click here to pre-book a meeting time with us, or stop by booth 2172 and meet with a team member to discuss the latest developments in preclinical research for gene and cell therapy.

We look forward to meeting you in Baltimore!

Our Services

for Cell & Gene Therapy Development

Noble Life Sciences is a full-service preclinical contract research organization offering GLP and non-GLP services, including safety and efficacy testing, for the development of drugs, vaccines, and medical devices.

IND Enabling Studies For Cell & Gene Therapy

  • Biodistribution & Persistence Studies
    • Digital PCR & Quantitative PCR
    • Flow Cytometry
  • Safety Studies
    • Tumor Bearing Models
    • Humanized Mouse Models
  • Therapeutic Agents
    • Cell-based Therapeutics (CAR-T, IPSC)
    • Cancer Vaccines
    • Nucleic Acid Vaccines & Therapeutics
    • Nanoparticle Vaccines & Therapeutics
    • Viral-derived Gene Therapies (AAV, Adeno, Lenti) 

Oncology CRO Services

  • GLP and Non-GLP Toxicology Studies
  • Mouse Efficacy Models
    • Xenograft
    • Syngeneic
    • Humanized Mice
    • Orthotopic Implantation
    • Bioluminescent Tumor Models
  • Assay Services
    • Digital PCR
    • Quantitative PCR
    • Flow Cytometry
    • Immunophenotyping

    Announcing a new partnership with Accelevir

    See Us at Booth 2172

    Accelevir is a Maryland-based biotechnology company developing and enabling innovative assays for ultra-rare analytes. We are driven by a strong scientific ethos with continual advancement of our operational standards. We advance disruptive technologies to market for enabling cure programs.

    Services Accelevir offers in collaboration with Noble for cell and gene therapy development include the following. Talk to our experts for your cell product development and clinical biomarker studies.

    • Cell Product Characterization
      • Vector Copy Number and Integrity
      • Gene Editing Efficiency
      • Integration Site Analysis

    • Multiple Tumor Efficacy Models
      • Bioluminescent and Humanized Models
    • GLP Biodistribution, Persistence & Shedding
      • Multiplex Digital & Quantitative PCR for Rare Targets

     

    • Translate Your Biomarker Assays from Preclinical to Clinical Trials
      • PBMC Processing, Phenotyping, and Storage

    Meet the Noble Attendees

    See Us at Booth 2172

    Arundhati Ghosh, Ph.D., MSc.

    Study Director

    Pang-Kuo Lo

    Pang-Kuo Lo, Ph.D. MSc.

    Team Lead, Assay Development

    Edwin Gershom

    Haimi Shiferaw

    Client Services Representative

    Visit Us at Booth 2172

    ASGCT 27th Annual Meeting

    May 7—11, 2024 | Baltimore Convention Center, Baltimore, MD

    Noble Life Sciences, is a global preclinical CRO dedicated to innovation and scientific discovery. With a proven track record in navigating the complexities of preclinical research, our dedicated team is poised to be your strategic partner in advancing your scientific initiatives, including gene and cell therapy

    The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting is the premier event for professionals in gene and cell therapy. The meeting is the best place for people in the field to learn from the latest scientific research, stay up to date on new technologies, and make career-advancing connections with peers.